5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

Show other versions (1)

Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-03-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	CMML, 5-azacytidine
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/317
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01)

Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report
by: Grace S. Park, et al.
Published: (2025-01-01)

Improvement of Monacolin K and Pigment Production in <i>Monascus</i> by 5-Azacytidine
by: Chan Zhang, et al.
Published: (2024-11-01)

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
by: Petra Bašová, et al.
Published: (2025-01-01)

Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
by: IOANNIS KOTSIANIDIS
Published: (2019-06-01)

The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID
by: Antonio Cristiano, et al.
Published: (2022-04-01)

Kütüphanelerde Değişim Yönetimi Uygulamalarının CMML ve CMML-CS İle İzlenmesi: Marmara Üniversitesi Merkez Kütüphanesi Örneği
by: Asiye Kakırman Yıldız
Published: (2010-06-01)

miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
by: Yilan Xu, et al.
Published: (2025-02-01)

SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
by: Livio Pagano, et al.
Published: (2011-01-01)

SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
by: Francesco D'Alò, et al.
Published: (2011-11-01)

Evaluation of Drug Effectiveness and Controlled Release Profiles of Clay Minerals Loaded with Anti-Carcinogenic Agent as a Drug Delivery System on Leukemia
by: Duran M, et al.
Published: (2024-12-01)

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
by: Ziyi Hao, et al.
Published: (2024-12-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Caterina Giovanna Valentini, et al.
Published: (2011-12-01)

INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
by: Morena Caira, et al.
Published: (2011-01-01)

Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia
by: Jingying Cui, et al.
Published: (2024-12-01)

AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.
by: Pasquale Niscola
Published: (2014-02-01)

Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease
by: Feng Li, et al.
Published: (2018-01-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE
by: Luana Fianchi, et al.
Published: (2021-04-01)

EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE
by: Luana Fianchi, et al.
Published: (2021-04-01)

Paraneoplastic Autoimmunity Associated with Testicular Myeloid Sarcoma and Chronic Myelomonocytic Leukemia
by: Jeffrey W. Craig, et al.
Published: (2013-01-01)

A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia
by: Sylwia Sasinowska, et al.
Published: (2017-01-01)

Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)
by: Anthony Crymes, et al.
Published: (2024-01-01)

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia?
by: Prasun Pudasainee, et al.
Published: (2019-01-01)

Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation
by: Emiko Kashima, et al.
Published: (2024-12-01)

Knockdown of Methylation‐Related Gene MBD2 Blocks Cell Growth by Upregulating p21 Expression in Head and Neck Squamous Cell Carcinoma
by: Ting Cao, et al.
Published: (2024-12-01)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
by: Xiaoling Liu, et al.
Published: (2012-01-01)

Unusual transformation from refractory anemia to chronic myelomonocytic leukemia: a case report.
by: Pasquale Niscola
Published: (2014-08-01)

Extramedullary Hematopoiesis in a Sentinel Lymph Node as an Early Sign of Chronic Myelomonocytic Leukemia
by: Joslin M. Bowen, et al.
Published: (2015-01-01)

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
by: Elena Elli, et al.
Published: (2012-01-01)

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
by: Elena Elli, et al.
Published: (2012-03-01)

Prognostic Significance and Treatment Response Associations of Genetic Mutations in Chronic Myelomonocytic Leukemia: A Retrospective Cohort Study
by: Jing Di, et al.
Published: (2024-10-01)

Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura
by: Masao Hagihara, et al.
Published: (2016-01-01)

CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
by: Kelly Lim, et al.
Published: (2024-01-01)

Juvenile myelomonocytic leukemia with G6PD deficiency: A case report
by: Akhila Gujarathi, et al.
Published: (2024-01-01)

Mapping of the mutational landscape of Juvenile Myelomonocytic Leukemia patients by whole exome sequencing
by: Aditya Kumar Gupta, et al.
Published: (2024-01-01)

CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
by: Livio Pagano, et al.
Published: (2009-11-01)

CASE PRESENTATION: TREATMENT AND FOLLOW-UP EXPERIENCE FROM MYELODYSPLASTIC SYNDROME (MDS) REAB II TO CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
by: Harika Shundo, et al.
Published: (2024-12-01)